End stage non-small cell lung cancer
Conditions
Interventions
Control group (hospice treatment group, simulant + hospice care):Bufei Tang granule simulant, 1 bag each time, twice a day, washed with warm water. Joint hospice care.
Test group (observation group, Bufei Decoction + hospice care):Bufei Decoction granules, 1 bag each time, twice a day, washed with warm water. Joint hospice care.
DZ01SY02
Sponsors
Beijing Gulou Hospital of traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: ? The diagnosis of advanced non-small cell lung cancer (stage ? b- ?) is supported by cellular and pathological diagnosis. ? Those who meet the above diagnostic criteria of Chinese and Western medicine are patients with Qi deficiency syndrome. ? On the premise that the patient fully understands the condition, the estimated survival time can reach 3 months or more. ? The patient knows all the contents of hospice care, and the patient is too weak to receive anti-cancer treatment, or the patient refuses to continue anti-cancer treatment; ? No mental illness and consciousness disorder, can communicate normally; ? On the premise of full knowledge, the patients voluntarily participated in the study, agreed to follow-up and were qualified. ? No treatment with traditional Chinese medicine within 3 months before treatment.
Exclusion criteria
Exclusion criteria: ? Lung cancer was diagnosed as non primary, and the pathological findings did not belong to non-small cell lung cancer. There were other malignant tumors except primary non-small cell lung cancer. ? There are serious primary diseases such as cardiovascular and cerebrovascular diseases, or other serious diseases such as liver and kidney dysfunction. ? A woman who is breast-feeding or pregnant. ? Patients with disabilities specified by law, including blindness, deafness, muteness, intellectual or mental disorders, and physical disabilities. ? Have a definite history of food and drug allergy, have a clear experience of allergy to the ingredients contained in the drugs used in the experiment, and have an allergic constitution. ? For the purpose of ensuring the smooth progress of the experiment, the patients who are considered by the researcher to be unsuitable for enrollment or whose possibility of enrollment is too low. ? Patients who have not finished or are difficult to exclude the impact of other clinical studies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| EORTC QLQ-C30;ECOG;CFS; | — |
Countries
China
Contacts
Public ContactLi Tongda
Beijing Gulou Hospital of traditional Chinese Medicine
Outcome results
None listed